AbbVie to buy leukemia drugmaker Pharmacyclics for $21 billion in its first deal since Shire
March 05, 2015 at 00:32 AM EST
AbbVie Inc. says it is buying leukemia drugmaker Pharmacyclics for $21 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.